Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...

The results of CardinALS showed utreloxastat failed to meet its main and secondary goals, including several disease-related ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to ...

QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...

Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...

Bucknell men’s coach John Griffin got a text from his old college roommate, Patrick Behan. “No hero steals,” it read. ...

Country traveling group The Oak Ridge Boys, which has performed many shows at Crystal Grand Music Theatre, are coming back to ...

Please use this link to apply For over 70 years, MDA has led the way as the #1 Voluntary Health Organization in the U.S. for ...

A father from Oldham who was diagnosed with MND just weeks after his wedding can't leave his home without assistance due to inaccessibility.

Wedbush reaffirmed their outperform rating on shares of argenx (NASDAQ:ARGX – Free Report) in a report released on ...

Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment ...